CRT 2023

Panel Discussion: Digital Heath Apps in Clinical Trials: Ready for Prime Time?

Panel Moderator(s)

• 

  Jodi J. Akin, MS

  CEO
  Hawthorne Effect, Inc.
  Alamo, California, United States

  Disclosure information not submitted.
• 

  Joaquin E. Cigarroa, MD

  Head of the Division of Cardiovascular Medicine
  OHSU Knight Cardiovascular Institute
  Portland, Oregon, United States

  No relationships to disclose
• RK

  Robert Kazmierski, PhD

  Biomedical Engineer
  FDA / CDRH

  Disclosure(s): No financial relationships to disclose
• JP

  Jessica Paulsen

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Dominic Allocco, MD, MS

  Vice President, Clinical
  Boston Scientific, Minnesota, United States

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)
• KC

  Kimberly Crowley, MS (she/her/hers)

  Biomedical Engineer
  FDA

  Disclosure(s): No financial relationships to disclose
• 

  Peter J. Fitzgerald, MD, PhD

  Director, Center for CV Innovation
  Stanford University
  Stanford, California, United States

  No relationships to disclose